Tags - | ABPI

Gavi: Partnering to protect future generations from infectious diseases

As Gavi marks its twentieth anniversary, a new report from the ABPI and IFPMA looks at the past successes of the Vaccines Alliance and what the future holds. Richard Torbett looks ahead to that commitment to protect future generations from infectious diseases.

International Clinical Trials Day - how is COVID-19 affecting research?

On International Clinical Trials Day, Dr Sheuli Porkess considers the impact that COVID-19 is having on clinical trials and the potential lessons for the future research.

What new data tells us about Academia-Industry links

Malcolm Skingle CBE PhD, Chair of the ABPI's ACES Strategic Leadership Group, looks at the data from our most recent survey of academic-industry links.

Repurposing – what is it and why it’s important for COVID-19

COVID-19 has emerged as a brand new disease with a severe impact on patients, the public and health systems around the world.

Levelling up the country means playing to our strengths

The balance the Chancellor needs to strike in delivering his first Budget on Wednesday has been made even tougher by the need to prioritise measures to tackle coronavirus.

Rare diseases and clinical research: How can we maximise the chances of success?

Our President Haseeb Ahmad sets out how industry is working to find treatments and cures for some of the world’s most complex diseases. Nowhere is the need to find new medicines more acute than in rare diseases, many of which are genetic and affect the youngest patients.

A patient population of 3.5million people can’t be ignored

We spoke to Dr Lucy McKay, CEO of the charity Medics4RareDiseases. She told us why health professionals should ‘dare to think rare’ in their patients.

One thing I have learned while living with a rare disease is to never give up

Prabhjot is a is a university lecturer in living in London. She describes her experience of living with polymyositis.

Taking control: Inspiring others to beat rare diseases

Karen Owen lives with a condition called hereditary angioedema (HAE). She has learned to take control of HAE through self-management techniques and peer support.

More than just cold hands

February is Raynaud’s awareness month. Physiotherapist and Parkinson’s dance teacher Liz Hooks has the condition and for her, a little kindness and the offer of some hot water would go a long way to help manage it.

Early diagnosis is key to improve outcomes for patients

Professor Derralynn Hughes is Professor of experimental haematology based at the Royal Free London NHS Foundation Trust and University College London, and an expert on a group of rare diseases called lysosomal disorders.